Download Deliverying Clinical Research - Leicestershire Partnership NHS Trust

Type
NHS provider
Performance in Delivering
Leicestershire Partnership NHS Trust
Id
Research Ethics
Committee
Reference
Number
Name of Trial
74212
12/WA/0338
74213
13/EE/0249
74214
11/LO/1939
74215
13/EE/063
74216
14/WM/0166
74217
11/SW/0232
74218
14/NI/0069
74219
14/NW/0297
Reducing pathology in Alzheimer’s
Disease through Angiotensin
Targeting. The RADAR Trial. A phase
II, randomised, double blind, placebo
controlled trial to evaluate the effect
of Losartan on brain tissue in patients
diagnosed with Alzheimer’s disease
Developing and evaluating a
collaborative care intervention for
prisoners, with common mental
health problems, near to and after
release (Engager 2)
"Randomised controlled trial of the
clinical and cost-effectiveness of a
contingency management
intervention for reduction of cannabis
use and of relapse in early psychosis."
Minocycline in Alzheimer's disease
efficacy trial: The MADE Trial
"A randomised controlled trial
comparing the effects of providing
clinicians and patients with the
results of an objective measure of
activity and attention (QbTest) versus
usual care on diagnostic and
treatment decision making in children
and young people with ADHD"
"Physical activity programmes for
community dwelling people with mild
to moderate dementia (DAPA
Dementia And Physical Activity)"
AFFECT: A randomised controlled trial
of calcium channel blockade with
amlodipine for the treatment of
subcortical ischaemic vascular
dementia
EQUIP: Enhancing the quality of user
involved care planning in mental
health services (EQUIP): Clinical
Target
number
of
patients
available
Available
Target
number of
patients
Date Agreed to
recruit target
number of
patients
Trial Status
15
Date Agreed to
recruit target
number of
patients
available
Available
Target
met
within the
agreed
time
N
Comments
25/07/2014
Withdrawn
Available
12
Available
20/04/2014
Closed Follow Up
Complete
Y
First phase target achieved; second
phase now open
Available
10
Available
29/08/2014
Open
Y
Recruitment is on target for
completing by extended end date
locally. Study further extended
October 2015.
Available
15
Available
06/07/2014
Open
Y
Recruitment trajectory on target
Available
20
Available
25/11/2014
Closed - In
Follow Up
Y
Recruitment trajectory on time and
target
Available
36
Available
29/01/2014
Closed - In
Follow Up
Y
Available
20
Available
13/03/2015
Open
N
Recruitment has been below target,
but additional intervention groups
planned in further areas of the
County.
Sponsor Contracting delays led to
primary recruitment window missed.
Available
60
Available
22/10/2014
Open
Y
Delay in SIV; Delay in IMP Provision to
site; Delay in Processing MRI
Calibration. Study therefor closed by
site as no realistic prospect of "nocost extension" to study producing
good recruitment.
Ongoing recruitment: LPT is leading
UK site for this study.
74220
09/H1005/28
74221
14/SC/1340
randomised control trial and process
evaluation
Molecular genetics of adverse drug
reactions: from candidate genes to
genome wide association studies.
LEGATO-HD (Laquinimod Efficacy and
Safety in a GlobAl Trial Of
Huntingtons Disease)
Available
5
Available
01/10/2015
Open
N
Available
5
Available
28/09/2015
Open
N
CSO Lead initially unavailable through
Ill-health and no task force cover
available - contingency plan will cause
delay. Initial screening of clinic data
excluded the majority of cases.
First wave of participants did not
consent as travel to study centre seen
as burdensome - target therefore
overshot by a few days.